SenzaGen: The Non-Animal Alternative - Redeye

Redeye initiates coverage of SenzaGen, a Swedish commercial-stage MedTech company offering high-performance in-vitro technology tests that are set to capitalize on the trend toward animal-free testing in cosmetics, medical devices, chemicals, and pharmaceutical industries. Its updated growth-oriented commercial strategy, driven by an increased effort for acquisitions, offers a compelling case with 63% upside to our Base Case.

Länk till analysen i sin helhet: https://www.redeye.se/research/840691/senzagen-the-non-animal-alternative?utm_source=finwire&utm_medium=RSS